[1] Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA 2020;323:1061.
[2] Tian J, Yuan X, Xiao J, Zhong Q, Yang C, Liu B, Cai Y, Lu Z, Wang J, Wang Y, Liu S, Cheng B, Wang J, Zhang M, Wang L, Niu S, Yao Z, Deng X, Zhou F, Wei W, Li Q, Chen X, Chen W, Yang Q, Wu S, Fan J, Shu B, Hu Z, Wang S, Yang X, Liu W, Miao X, Wang Z. Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study. The Lancet Oncology 2020;21:893.
[3] Liang W, Liang H, Ou L, Chen B, Chen A, Li C, Li Y, Guan W, Sang L, Lu J, Xu Y, Chen G, Guo H, Guo J, Chen Z, Zhao Y, Li S, Zhang N, Zhong N, He J. Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19. JAMA INTERN MED 2020;180:1081.
[4] Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet (British edition) 2020;395:497.
[5] Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA : the journal of the American Medical Association 2020;323:1239.
[6] Guan W, Liang W, Zhao Y, Liang H, Chen Z, Li Y, Liu X, Chen R, Tang C, Wang T, Ou C, Li L, Chen P, Sang L, Wang W, Li J, Li C, Ou L, Cheng B, Xiong S, Ni Z, Xiang J, Hu Y, Liu L, Shan H, Lei C, Peng Y, Wei L, Liu Y, Hu Y, Peng P, Wang J, Liu J, Chen Z, Li G, Zheng Z, Qiu S, Luo J, Ye C, Zhu S, Cheng L, Ye F, Li S, Zheng J, Zhang N, Zhong N, He J. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. EUR RESPIR J 2020;55:2000547.
[7] Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet 2020;395:1054.
[8] National Health Commission of the People’s Republic of China.
Chinese management guideline for COVID-19 (version 7.0). March 3, 2020.
http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989/files/ce3e6945832a438eaae415350a8ce964.pdf (accessed March 27, 2020; in Chinese).
[9] Zhang B, Zhou X, Qiu Y, Song Y, Feng F, Feng J, Song Q, Jia Q, Wang J. Clinical characteristics of 82 cases of death from COVID-19. PLOS ONE 2020;15:e235458.
[10] Chen XQ, Xue CR, Hou P, Lin BQ, Zhang JR. Lymphocyte-to-monocyte ratio effectively predicts survival outcome of patients with obstructive colorectal cancer. World J Gastroenterol 2019;25:4970.
[11] Zhang HF, Ge YL, Wang HY, Zhang Q, Li WQ, Chen Y, Chen QC, Jin JJ, Xu J, Zhang S, Xu TT, Zhang X, Yu HL, Zhu XY, Liu CH, Bai J, Zhang JB, Xie BQ, Wang Y, Fu AS, Zhang PP. Neutrophil-to-Lymphocyte Ratio Improves the Accuracy and Sensitivity of Pneumonia Severity Index in Predicting 30-Day Mortality of CAP Patients. CLIN LAB 2019;65.
[12] Ge YL, Zhang HF, Zhang Q, Zhu XY, Liu CH, Wang N, Zhang JB, Chen H, Chen Y, Li WQ, Li ZZ, Fu AS, Wang HY. Neutrophil-to-Lymphocyte Ratio in Adult Community-Acquired Pneumonia Patients Correlates with Unfavorable Clinical Outcomes. CLIN LAB 2019;65.
[13] Chen R, Sang L, Jiang M, Yang Z, Jia N, Fu W, Xie J, Guan W, Liang W, Ni Z, Hu Y, Liu L, Shan H, Lei C, Peng Y, Wei L, Liu Y, Hu Y, Peng P, Wang J, Liu J, Chen Z, Li G, Zheng Z, Qiu S, Luo J, Ye C, Zhu S, Zheng J, Zhang N, Li Y, He J, Li J, Li S, Zhong N. Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China. J ALLERGY CLIN IMMUN 2020;146:89.
[14] Yang AP, Liu JP, Tao WQ, Li HM. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. INT IMMUNOPHARMACOL 2020;84:106504.
[15] Liu J, Liu Y, Xiang P, Pu L, Xiong H, Li C, Zhang M, Tan J, Xu Y, Song R, Song M, Wang L, Zhang W, Han B, Yang L, Wang X, Zhou G, Zhang T, Li B, Wang Y, Chen Z, Wang X. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. J TRANSL MED 2020;18:206.
[16] Fu J, Kong J, Wang W, Wu M, Yao L, Wang Z, Jin J, Wu D, Yu X. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China. THROMB RES 2020;192:3.
[17] Danwang C, Endomba FT, Nkeck JR, Wouna D, Robert A, Noubiap JJ. A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19). Biomark Res 2020;8:37.
[18] Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, Akdis CA, Gao YD. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. ALLERGY 2020;75:1730.
[19] Ke C, Yu C, Yue D, Zeng X, Hu Z, Yang C. Clinical Characteristics of confirmed and clinically diagnosed patients with 2019 novel coronavirus pneumonia: a single-center, retrospective, case-control study. Med Clin (Barc) 2020.
[20] Zeng Z, Yu H, Chen H, Qi W, Chen L, Chen G, Yan W, Chen T, Ning Q, Han M, Wu D. Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China. CRIT CARE 2020;24:525.
[21] Dong YM, Sun J, Li YX, Chen Q, Liu QQ, Sun Z, Pang R, Chen F, Xu BY, Manyande A, Clark TG, Li JP, Orhan IE, Tian YK, Wang T, Wu W, Ye DW. Development and Validation of a Nomogram for Assessing Survival in Patients with COVID-19 Pneumonia. CLIN INFECT DIS 2020.
[22] Wang B, Zhong F, Zhang H, An W, Liao M, Cao Y. Risk factors analysis and nomogram construction of non-survivors in critical patients with COVID-19. JPN J INFECT DIS 2020.